Data as of Aug 16, 2026 · Based on 3,131,739 AI responses across 10,525 prompts · See how Parse measures this
Nova In Siliconovainsilico.ai · Low evidenceNova In Silico provides a collaborative clinical trial simulation platform called jinkō that predicts clinical outcomes before human trials. The platform combines data science, biology, and medicine to reduce trial duration, risk, and burden through virtual patient simulations.
Parse Score
Sources
novainsilico.ai shapes more of what AI says about Nova In Silico than any other source, at 100% of its citations.